iShares Neuroscience and Healthcare ETF (IBRN): ETF
ETF traded on ARCX under symbol IBRN. Quoted in usd.
iShares Neuroscience and Healthcare ETF
+2.83%$33.83
ARCX:IBRNEquity
AUM $6.77M·YTD --·Yield --
ARCX:IBRN$33.83+2.83%AUM $6.77MTop Holdings
44.1% of portfolio in top 10 holdings
Concentrated in Health Care (99.3%)
Performance:
 | BIIB BIOGEN | +11.42% | 1.8K | |
 | NBIX NEUROCRINE BIOSCIENCES | +13.14% | 2.6K | |
 | EWTX EDGEWISE THERAPEUTICS | -- | 9.3K | |
 | ALKS ALKERMES | +10.20% | 8.7K | |
 | PTCT PTC THERAPEUTICS | +2.73% | 5.8K | |
 | ARGX ARGENX SE ADR | -0.36% | 387 | |
 | SRRK SCHOLAR ROCK HOLDING | +10.58% | 7.2K | |
 | AXGN AXOGEN | +37.76% | 6.6K | |
 | 326030.KS SK BIOPHARMACEUTICALS LTD | -- | 5.0K | |
 | DNTH DIANTHUS THERAPEUTICS | +0.74% | 3.7K | |
 | PRAX PRAXIS PRECISION MEDICINES | -0.90% | 1.1K | |
 | ACAD ACADIA PHARMACEUTICALS | -- | 14.3K | |
 | DYN DYNE THERAPEUTICS | +17.34% | 16.4K | |
 | HLUN-B.CO H. LUNDBECK CLASS B | -- | 33.7K | |
 | XENE XENON PHARMACEUTICALS | -- | 6.7K | |
 | BHVN BIOHAVEN | -- | 16.2K | |
 | SRPT SAREPTA THERAPEUTICS | +2.95% | 12.7K | |
 | NEU.AX NEUREN PHARMACEUTICALS | -- | 13.9K | |
 | BIOA-B.ST BIOARCTIC CLASS B | -- | 5.4K | |
 | 4588.T ONCOLYS BIOPHARMA INC | -- | 3.2K | |
 | TSHA TAYSHA GENE THERAPIES | -1.37% | 33.5K | |
 | LBRX LB PHARMACEUTICALS INC | -- | 3.3K | |
USD CASH Cash | -- | 129.4K | ||
 | IDIA.SW IDORSIA N LTD | -- | 23.7K | |
 | RUBICON.NS RUBICON RESEARCH | -- | 6.4K |
Institutional Holders
Sector Breakdown
| Sector | Weight |
|---|---|
| Health Care | 99.30% |
| Information Technology | 1.15% |
| Cash and/or Derivatives | -0.46% |
Holdings Treemap
Country Allocation
| Country | Weight |
|---|---|
| United States | 72.87% |
| Belgium | 4.21% |
| South Korea | 4.06% |
| Denmark | 3.42% |
| Sweden | 3.18% |
| Australia | 2.73% |
| Japan | 2.39% |
| Switzerland | 2.21% |
| China | 1.48% |
| India | 1.44% |
| France | 1.17% |
| Other | 0.85% |